en

PRODUCT DETAIL

Neupro 4 mg/24 h transdermálna náplasť

Code 98651
MA number EU/1/05/331/005
Product Form: emp tdm 28x4 mg/24 hodín (vre.pap./LDPE/Al/ET kopolymér PE/Al/ET kopolymér/pap.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: UCB Pharma S.A. , Belgium
Therapeutic Class: 27 - ANTIPARKINSONICA
ATC:
N NERVOUS SYSTEM
N04 ANTI-PARKINSON DRUGS
N04B DOPAMINERGIC AGENTS
N04BC Dopamine agonists
N04BC09 Rotigotine
Shelf life: 30
Container: sachet paper/LDPE/alu/ and copolymer - PET/alu and copolymer/paper
Route of admin.: Transdermal use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 15.02.2006
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 19.06.2018
eu-flag.png sk-flag.png